abiomed.e see the number to give you. 252. indicated 375. it is down a little bit. it is cash $16.6 billion which includes some cash, i guess with abiomed shareholder has. shareholders will receive up to $35 in cash of certain milestones are received. this is the johnson & johnson med tech position in cardiovascular disease and standard care and health care largest disease states and heart failure and recovery abiomed is a world leader in heart, lung and kidney support technologies the ceo of johnson & johnson says the addition of abiomed is an important step in the execution of our strategic priorities and vision for a new johnson & johnson focused on pharma and med tech. i guess, let's see, it has been around for 18 years of a track record of viable growth, abiomed. we have not seen anything with this market we're in this is almost $17 billion it is cash we are pleased to reach agreement with the remarkable value that abiomed created in the revolutionary in impela heart pump platform. not ev

stop war profiteering or face a windfall tax >>> and jnj-abiomed is a 16.16 all cash deal. >> let's begin with the new month of trading the fed set to kick off its two-day policy meeting jim, we have had multiple reports that disinflation has begun. bonds starting to tick below the average. >> and a lot of fiscal years, 50% of the mutual funds, had their fiscal year end at the end of october, which means that you might have seen some selloff in stocks that people seriously don't want to show they own. you see traditional bounce worst acting stock in the s&p. i think deservedly one of the things, and, david, you know this, it's very small si simon and shoes shuster. >> we will talk a little bit later in the show. a deal many anticipated would be opposed by the government, was, and they prevailed in court. namely the -- >> if the government decides for biomed and j&j could be in that business i'm saying -- in there is no overlaps >> it's such an important deal j&j is splitting in two. >> yes >> they are going to the consumer group and they are going med tech and pharma >> they have a cvr ov

a big m&a transaction, johnson & johnson will acquired aboimed, at a 58% premium abiomed shares surgingthere's hologic getting a big pop. the medical technology company that makes diagnostic products seeing, quote, unprecedented strength across the core businesses, with 2023 earnings guidance coming in better than some analysts feared joining us is ceo steve mcmillan good to see you. >> good to see you again. >> so i pulled out the quote, i read the quote there, unprecedented strength in the core business. we've been talking to you throughout covid where you fully transitioned to these pcr tests. does this mean that it's a return to normal in other diagnostic testing >> i think what it really means is we quietly transformed the company. obviously you know and you've been on the front lines of reporting what a great job our team did responding to covid we used the proceeds to really invest in some additional r&d and targeted acquisitions so where we enter '23 with all four of our major businesses, skeletal health, diagnostics and surgery, all poised to grow double digit rates next year i

med skyrocketing, jnj paying 380 a share up front plus extra 35 dollars if certain conditions met, abiomed heart pumps for clogged arteries, stock up 52 a percent on the buy, jnj down half a percent a week away from midterm elections president biden, presence is largely muted in the run-up to the election, tennessee senator bill hagerty is here. >> ♪ now that thing that i said got their heads -- that i want, they don't know what the spirit is like. ♪ . i remember when i first started flying, and we would experience turbulence. i would watch the flight attendants. if they're not nervous, then i'm not going to be nervous. financially, i'm the flight attendant in that situation. the relief that comes over people once they know they've got a guide to help them through, i definitely feel privileged to be in that position. ♪ what if “just an idea” could become a family tradition? this is financial security. and lincoln financial solutions will help you get there. as you plan, protect and retire. ♪ xfinity rewards is a program whose sole purpose is to say as you plan, protect and retire. "thank y

. >> a big med tech deal johnson & johnson scooping up abiomed for over $16 billion, surging 50%. ceo saying the company will look to build up their medical device unit through acquisitions so should we expect more m&a in the space, karen what do you think? >> yes, i think so i feel like this whole sector is -- they're gigantic, first of all. this is a big deal, $17 billion. to j&j, this is not a big deal at all so there is a lot of these potential targets that are out there. merck just announced a deal. and lilly. they're all huge they're quarter of a trillion dollars plus so they could all afford to do acquisitions if they wanted to i mean, for them, borrowing is available if they want it or if they have cash on their balance sheet. and there sort of a psychological element to it. if you see your friend, the ceo of yyz corp. doing a deal, i'm telling you, it sounds ridiculous, but you might have this idea of all right, it's safe to do now, right? >> yeah. >> it feels safe and there is some cover. if we're all doing deals, no individual one of us will look dumb if they don't work

abiomed develops heart pumping technologies. and uber reported recovery with increased ridership.oncerns that rising inflation cut into the number of people taking uber. global news 24 hours a day on air and on bloomberg quicktake, powered by more than 2700 journalists and analysts in over 120 countries. i'm lisa mateo. this is bloomberg. ♪ >> what we do need is people pulling together to address the production issues. you could have a crisis and you need people cooperating. jonathan: brilliant to hear from the chairman at s&p there. from new york city this morning, good morning. here's your equity market, up 1%. just got a message from michael who said this, the rangers are pitching against the phillies tonight. tom: because of the rain? interesting. that's a good correction. jonathan: stick to football in the future. tom: you getting big response from the ncaa. jonathan: lsu, saturday night. tom: i just liked purdue. destined. wanted to play 500 ball. something like that. putting it up 6% on the 4100. jonathan: far and away. sure. tom: looking at washington right now, we do this